These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31842258)

  • 1. Toward Engineering the Mannose 6-Phosphate Elaboration Pathway in Plants for Enzyme Replacement Therapy of Lysosomal Storage Disorders.
    Zeng Y; He X; Danyukova T; Pohl S; Kermode AR
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31842258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and downstream mannose phosphorylation of human recombinant α-L-iduronidase produced in Arabidopsis complex glycan-deficient (cgl) seeds.
    He X; Pierce O; Haselhorst T; von Itzstein M; Kolarich D; Packer NH; Gloster TM; Vocadlo DJ; Qian Y; Brooks D; Kermode AR
    Plant Biotechnol J; 2013 Dec; 11(9):1034-43. PubMed ID: 23898885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-glycan structures and downstream mannose-phosphorylation of plant recombinant human alpha-L-iduronidase: toward development of enzyme replacement therapy for mucopolysaccharidosis I.
    Pierce OM; McNair GR; He X; Kajiura H; Fujiyama K; Kermode AR
    Plant Mol Biol; 2017 Dec; 95(6):593-606. PubMed ID: 29119347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of enzymatically active human alpha-L-iduronidase in Arabidopsis cgl (complex glycan-deficient) seeds.
    Downing WL; Galpin JD; Clemens S; Lauzon SM; Samuels AL; Pidkowich MS; Clarke LA; Kermode AR
    Plant Biotechnol J; 2006 Mar; 4(2):169-81. PubMed ID: 17177794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannose-6-phosphate glycan for lysosomal targeting: various applications from enzyme replacement therapy to lysosome-targeting chimeras.
    Seo J; Oh DB
    Anim Cells Syst (Seoul); 2022; 26(3):84-91. PubMed ID: 35784393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.
    Unger EG; Durrant J; Anson DS; Hopwood JJ
    Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):43-9. PubMed ID: 7998955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.
    Baldo G; Quoos Mayer F; Burin M; Carrillo-Farga J; Matte U; Giugliani R
    Cells Tissues Organs; 2012; 195(4):323-9. PubMed ID: 21778683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on mannose 6-phosphate residue contents of recombinant lysosomal enzymes.
    Togawa T; Takada M; Aizawa Y; Tsukimura T; Chiba Y; Sakuraba H
    Mol Genet Metab; 2014 Mar; 111(3):369-373. PubMed ID: 24439675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.
    Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP
    Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of an ER-retention signal on the N-glycosylation of recombinant human α-L-iduronidase generated in seeds of Arabidopsis.
    He X; Haselhorst T; von Itzstein M; Kolarich D; Packer NH; Kermode AR
    Plant Mol Biol; 2012 May; 79(1-2):157-69. PubMed ID: 22442036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RTB lectin-mediated delivery of lysosomal α-l-iduronidase mitigates disease manifestations systemically including the central nervous system.
    Ou L; Przybilla MJ; Koniar B; Whitley CB
    Mol Genet Metab; 2018 Feb; 123(2):105-111. PubMed ID: 29198892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein.
    Boado RJ; Pardridge WM
    Mol Pharm; 2017 Apr; 14(4):1271-1277. PubMed ID: 28279069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs.
    Salvetti A; Moullier P; Cornet V; Brooks D; Hopwood JJ; Danos O; Heard JM
    Hum Gene Ther; 1995 Sep; 6(9):1153-9. PubMed ID: 8527473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein.
    Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM
    Mol Pharm; 2011 Aug; 8(4):1342-50. PubMed ID: 21667973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four unreported types of glycans containing mannose-6-phosphate are heterogeneously attached at three sites (including newly found Asn 233) to recombinant human acid alpha-glucosidase that is the only approved treatment for Pompe disease.
    Park H; Kim J; Lee YK; Kim W; You SK; Do J; Jang Y; Oh DB; Il Kim J; Kim HH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2418-2424. PubMed ID: 29274340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic expression of a conifer Abscisic Acid Insensitive3 transcription factor induces high-level synthesis of recombinant human alpha-L-iduronidase in transgenic tobacco leaves.
    Kermode AR; Zeng Y; Hu X; Lauson S; Abrams SR; He X
    Plant Mol Biol; 2007 Apr; 63(6):763-76. PubMed ID: 17203373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Analysis of Lysosomal Directed Proteins and Their Sites of Mannose-6-phosphate Modification.
    Čaval T; Zhu J; Tian W; Remmelzwaal S; Yang Z; Clausen H; Heck AJR
    Mol Cell Proteomics; 2019 Jan; 18(1):16-27. PubMed ID: 30237200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of a recombinant human alpha-L-iduronidase (laronidase) by cultured fibroblasts and osteoblasts.
    Tsukimura T; Tajima Y; Kawashima I; Fukushige T; Kanzaki T; Kanekura T; Ikekita M; Sugawara K; Suzuki T; Togawa T; Sakuraba H
    Biol Pharm Bull; 2008 Sep; 31(9):1691-5. PubMed ID: 18758061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanidinylated Neomycin Conjugation Enhances Intranasal Enzyme Replacement in the Brain.
    Tong W; Dwyer CA; Thacker BE; Glass CA; Brown JR; Hamill K; Moremen KW; Sarrazin S; Gordts PLSM; Dozier LE; Patrick GN; Tor Y; Esko JD
    Mol Ther; 2017 Dec; 25(12):2743-2752. PubMed ID: 28958576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.